Hepion Pharmaceuticals, Inc. (HEPA) stock
HEPAOTCPharmaceutical PreparationsFiscal year ends December 31Also trades as CTRVP
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q/A on Nov 17, 2026Score 1/30
$0.10−0.00 (-1.45%)
Close on Oct 19, 2026Market cap $7.26MP/E –Yield –
Hepion Pharmaceuticals price to book ratio
The price-to-book ratio is market cap divided by shareholders' equity.
Hepion Pharmaceuticals's price to book ratio was 2.3× on Oct 19, 2026, against 0.2× a year earlier. Over the last 5 years it ranged from 0.1× to 11.4×, with a median of 0.8×.
Price to Book Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Oct 19, 2026 | 2.3× | +2.1 |
| 2025 | Dec 31, 2025 | 0.2× | −7.8 |
| 2024 | Dec 31, 2024 | 8.0× | +7.3 |
| 2023 | Dec 29, 2023 | 0.8× | +0.4 |
| 2022 | Dec 30, 2022 | 0.4× | −0.5 |
| 2021 | Dec 31, 2021 | 0.8× | −0.7 |
| 2020 | Dec 31, 2020 | 1.5× | +0.4 |
| 2019 | Dec 31, 2019 | 1.2× | +0.9 |
| 2018 | Dec 31, 2018 | 0.3× | −2.7 |
| 2017 | Dec 29, 2017 | 3.0× | −46.8 |
| 2016 | Oct 31, 2016 | 49.8× | +39.3 |
| 2015 | Oct 30, 2015 | 10.5× | −81.6 |
| 2014 | Dec 31, 2014 | 92.1× | – |
See a number that looks wrong?